Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.5K
1.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.7K
2.7K
Cancer02:18

Cancer

51.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preserving Medical Education in Conflict Zones through Transnational Partnerships: Field Lessons from Gaza and Ukraine.

Disaster medicine and public health preparedness·2026
Same author

Ayushman Arogya Mandir and India's progress toward Universal Health Coverage: A narrative review.

Journal of family medicine and primary care·2026
Same author

Survival comparison analysis between cervical squamous cell carcinoma and adenocarcinoma with a special focus on the HPV status.

Gynecologic oncology·2026
Same author

Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinoma.

Gynecologic oncology·2025
Same author

Impact of molecular and immune signature on endometrial biopsies with atypical hyperplasia with and without concurrent endometroid carcinoma.

Gynecologic oncology reports·2025
Same author

30-hydroxygambogic acid increases the efficacy of cisplatin in an HPV<sup>+</sup> head and neck cancer in vivo model.

BMC cancer·2025

Related Experiment Video

Updated: May 5, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K

Gynecologic cancers: molecular updates.

Quratulain Ahmed1, Baraa Alosh, Sudeshna Bandyopadhyay

  • 1Department of Pathology, Wayne State University, 540, E Canfield, Detroit, MI 48201, USA.

Clinics in Laboratory Medicine
|November 26, 2013
PubMed
Summary

This review explores the molecular characteristics and development of gynecologic cancers. Understanding endometrial carcinoma's molecular basis aids in predicting tumor prognosis and developing new treatments.

Keywords:
Endometrial carcinomaMolecular pathogenesisOvarian carcinomaUterine carcinoma

More Related Videos

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

1.1K
Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

14.8K

Related Experiment Videos

Last Updated: May 5, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

1.1K
Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

14.8K

Area of Science:

  • Gynecologic Oncology
  • Molecular Pathology
  • Cancer Biology

Background:

  • Gynecologic malignancies represent a significant global health challenge.
  • Understanding the molecular underpinnings of these cancers is crucial for advancing patient care.
  • Endometrial carcinoma, a common gynecologic malignancy, exhibits diverse molecular features influencing its clinical behavior.

Purpose of the Study:

  • To review the current understanding of molecular features in gynecologic malignancies.
  • To elucidate the pathogenesis of these cancers at a molecular level.
  • To highlight how molecular insights into endometrial carcinoma can inform prognosis and therapeutic strategies.

Main Methods:

  • Literature review of peer-reviewed scientific articles.
  • Analysis of molecular data related to gynecologic tumor development.
  • Synthesis of information on pathogenesis and molecular classification.

Main Results:

  • Gynecologic cancers are characterized by specific molecular alterations.
  • The pathogenesis involves complex genetic and epigenetic changes.
  • Molecular profiling of endometrial carcinoma correlates with tumor behavior and patient outcomes.

Conclusions:

  • A deeper understanding of molecular features is essential for diagnosing and treating gynecologic cancers.
  • Molecular insights provide a basis for personalized medicine approaches in endometrial carcinoma.
  • Further research into molecular pathways will drive the development of targeted therapies.